Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Aurora Cannabis Inc.TSX: ACB.TO

Cost of Revenue · Q4 FY2026 · quarter ended Mar 2026

Cost of revenue dips below year-ago levels

Q4 FY2026 cost of revenue of CA$19.89M fell 71.0% year over year, behind the +40.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 77.6% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.

Context

  • Cost of revenue amounted to 94.8% of revenue in FY2026, up 49.4 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -71.0% toward the trailing-twelve-month pace of +40.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$19.89M-77.6% QoQ
Last fiscal yearMar 2026
CA$303.89M+95.2% YoY
LTMMar 2026
CA$218.14M+40.1% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-71.0%——
1 year+95.2%——
3-year CAGR+0.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

CAD · from the income statement

Latest · FY2026
303.89M CAD
Year-over-year change
+95.2%
4-year CAGR
+11.0%

Cost of Revenue vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +40.1% is the 3rd highest of 8, against a peer median of +32.6%.
  • Cost of revenue amounts to 68.5% of revenue for ACB.TO, versus a peer median of 52.5%.
ACB.TO Competitors
Cost of Revenue for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$282.6M CAD+116.3%—103.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$237.39M CAD+25.3%-20.7%76.4%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$218.14M CAD+40.1%+0.7%68.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$128.47M USD-10.2%-13.4%49.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$83.17M CAD+37.3%-6.0%52.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$12.97M USD+17.0%+63.9%25.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$4.95M CAD+344.3%+123.1%179.2%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$3.99M USD+32.6%+252.4%7.8%
Peer median (excluding ACB.TO) —+32.6%+28.9%52.5%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.